top of page

Year:
2008
Vertical:
Health & Nutrition
Ranking:
Top 10
PiKe Pharma GmbH
PiKe Pharma GmbH develops small-molecule drugs for infectious diseases employing fragment-based synthesis of unique chemical libraries in combination with an innovative screening technology for the identification of novel protein-protein interaction inhibitors. The company was liquidated in 2015.

bottom of page